Come up with a name for your new list and we'll add to it:
MAX BioPharma raised a round of funding on October 07, 2013. Investors include
National Institutes of Health.
MAX BioPharma is a start up biopharmaceutical company engaged in discovery and development of small molecules to target human disorders including non-healing bone fractures, osteoporosis, and cancer. …